HER2+ breast cancer treatment and cardiotoxicity: monitoring and management.

Guy JerusalemPatrizio LancellottiSung-Bae Kim

Published in: Breast cancer research and treatment (2019)

The future of cardiotoxicity management in patients with HER2+ breast cancer is discussed, with a focus on novel techniques to improve cardiac outcomes, including new imaging modalities, biomarkers, interventional therapies, and ongoing trials.

Keyphrases

high resolution
left ventricular
current status
heart failure
metabolic syndrome
combination therapy
mass spectrometry
young adults
photodynamic therapy
skeletal muscle